Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Amir Moradi

Otolaryngology Vista, CA Medical Doctor

NPI 1467567032 CMS profile 21600

2023 West Vista Way, Suite F, Vista, CA 92083

Open in the dashboard

General payments

$389,280

502 records reported · program years 2019–2025

Research payments

$88,085

Paid to them · 53 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$2,192,714 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Amir Moradi of Vista, CA is reported in the CMS Open Payments database as having received $389,280 across 502 general payments and $88,085 in research payments paid to them. Separately, studies naming them as principal investigator received $2,192,714 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Otolaryngology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

12 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $99,578 71
2025 Research $1,096 10
2024 General $40,385 57
2024 Research $5,554 7
2023 General $106,462 142
2023 Research $76,870 22
2022 General $54,408 84
2022 Research $383 6
2021 General $25,314 41
2021 Research $4,181 8
2020 General $21,079 52
2019 General $42,054 55

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Amir Moradi
  • Otolaryngology median
  • Middle half of Otolaryngology
  • National median

In program year 2025, general payments to Amir Moradi were reported at $99,578. Among 6,588 Otolaryngology profiles paid that year, the median was $317 and the middle half received between $125 and $815.

Show as a table
Year Amir Moradi Otolaryngology median Middle half National median
2019 $42,054 $194 $82–$512 $163
2020 $21,079 $118 $42–$280 $114
2021 $25,314 $167 $63–$444 $132
2022 $54,408 $216 $84–$545 $149
2023 $106,462 $235 $93–$588 $160
2024 $40,385 $280 $111–$699 $164
2025 $99,578 $317 $125–$815 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. AbbVie, Inc. $232,946 287 payments
  2. Allergan Inc. $85,704 156 payments
  3. Merz North America, Inc. $45,641 38 payments
  4. Galderma Laboratories, L.P. $24,843 16 payments
  5. Revance Therapeutics, Inc. $101 4 payments
  6. Endo Pharmaceuticals Inc. $46 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $322,366 62 payments
  2. Travel and Lodging $29,427 61 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $26,636 54 payments
  4. Food and Beverage $8,461 220 payments
  5. Education $2,390 105 payments
Products named General payments · program years 2019–2025
  1. BOTOX $33,904 97 payments
  2. Xeomin $32,834 23 payments
  3. BOTOX COSMETIC $31,679 74 payments
  4. ALLODERM $10,307 11 payments
  5. STRATTICE $800 1 payment
  6. ASCLERA $624 6 payments
  7. DAXXIFY $101 4 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Merz North America, Inc. $69,109 4 payments
  2. AbbVie, Inc. $15,295 48 payments
  3. Allergan Inc. $3,681 1 payment

Records

555 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Otolaryngology in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record